Literature DB >> 10066087

The relationship between prognostic and predictive factors in the management of breast cancer.

I C Henderson1, A J Patek.   

Abstract

The discovery of new prognostic factors proceeds at a much more rapid pace than our knowledge of how to properly utilize this information in the management of patients with breast cancer, especially those with early breast cancer that has not metastasized to regional lymph nodes. Prognostic factors provide information on how the patient is likely to do regardless of treatment. Predictive factors provide information on whether a patient is likely to benefit from therapy. Most factors identified to date provide prognostic information, but relatively few provide information that is truly helpful in making a therapeutic decision in the management of individual patients. In large part this is because there has been insufficient study of the factor, especially prospective evaluations of the factor. Unfortunately this has resulted in the premature use of this information under the general rubric that patients with a poor prognosis deserve more treatment in spite of the fact that there may be no benefit from that therapy in the poor prognostic group.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10066087     DOI: 10.1023/a:1006141703224

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  39 in total

Review 1.  Triple-negative breast cancer: present challenges and new perspectives.

Authors:  Franca Podo; Lutgarde M C Buydens; Hadassa Degani; Riet Hilhorst; Edda Klipp; Ingrid S Gribbestad; Sabine Van Huffel; Hanneke W M van Laarhoven; Jan Luts; Daniel Monleon; Geert J Postma; Nicole Schneiderhan-Marra; Filippo Santoro; Hans Wouters; Hege G Russnes; Therese Sørlie; Elda Tagliabue; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

2.  Incidence of breast cancer in the United States: current and future trends.

Authors:  William F Anderson; Hormuzd A Katki; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2011-07-13       Impact factor: 13.506

3.  [Prognostic and predictive factors of invasive breast cancer: update 2009].

Authors:  T Decker; D Hungermann; W Böcker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

Review 4.  Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.

Authors:  Attiqa N Mirza; Nadeem Q Mirza; Georges Vlastos; S Eva Singletary
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

5.  Current status of the prognostic molecular biomarkers in breast cancer: A systematic review.

Authors:  Goro Kutomi; Toru Mizuguchi; Fukino Satomi; Hideki Maeda; Hiroaki Shima; Yasutoshi Kimura; Koichi Hirata
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

6.  Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Authors:  Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

7.  Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.

Authors:  William F Anderson; Philip S Rosenberg; Hormuzd A Katki
Journal:  J Natl Cancer Inst       Date:  2014-04-28       Impact factor: 13.506

Review 8.  Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.

Authors:  Christa K Baumann; Monica Castiglione-Gertsch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.

Authors:  Yogesh M Kulkarni; Vivian Suarez; David J Klinke
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

10.  Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.

Authors:  Judith-Anne W Chapman; Daniel Meng; Lois Shepherd; Wendy Parulekar; James N Ingle; Hyman B Muss; Michael Palmer; Changhong Yu; Paul E Goss
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.